Selection of a panel of monoclonal antibodies for monitoring residual disease in peripheral blood and bone marrow of interferon-treated hairy cell leukaemia patients.

Source:http://linkedlifedata.com/resource/pubmed/id/1702309

Download in:

View as

General Info

PMID
1702309